Golumbeski George

CIK 00015866607 companiesNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001586660

Recent Transactions

50 trades

Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2026-06-03+53,250→ 53,250 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-06-03+35,500→ 35,500 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2026-05-29+81,000→ 81,000 total
Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−8,637→ 0 total
Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−15,334→ 0 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2025-11-06+50,000→ 50,000 total
Disposition from Tender
Sage Therapeutics, Inc.
Common Stock
2025-07-31−8,000→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-31−21,500→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-31−13,593→ 0 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2025-07-14+33,150→ 33,150 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-11+21,500→ 21,500 total
Award
Mural Oncology plc
Stock Option (right to buy)
2025-06-11+8,637→ 8,637 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2025-01-03+13,593→ 13,593 total
Award
Mural Oncology plc
Stock Option (right to buy)
2024-07-30+15,334→ 15,334 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2024-06-21+27,700→ 27,700 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-10+12,500→ 12,500 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2024-01-03+3,495→ 3,495 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-15+10,000→ 10,000 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2023-05-26+40,258→ 40,258 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2023-01-04+2,108→ 2,108 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-16+9,947→ 9,947 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2022-06-08+40,258→ 40,258 total
Purchase
Sage Therapeutics, Inc.
Common Stock
2022-05-05$31.45/sh+8,000→ 8,000 total
Purchase
Shattuck Labs, Inc.$STTK
Common Stock
2022-04-26$3.63/sh+28,330→ 54,613 total
Purchase
Shattuck Labs, Inc.$STTK
Common Stock
2022-04-22$3.67/sh+234→ 26,283 total
Purchase
Shattuck Labs, Inc.$STTK
Common Stock
2022-04-21$3.69/sh+26,049→ 26,049 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2022-01-04+1,638→ 1,638 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2021-06-19+3,434→ 3,434 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2021-01-05+832→ 832 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2020-12-22+1,286→ 1,286 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2020-07-06+81,000→ 81,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-09+10,000→ 10,000 total
Award
ENANTA PHARMACEUTICALS INC$ENTA
Stock Option (right to buy)
2020-02-26+10,000→ 10,000 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2020-01-03+976→ 976 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-06-05+10,000→ 10,000 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Stock Option (Right to Buy)
2019-03-04−9,280→ 0 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2019-03-04$103.65/sh−9,280→ 0 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2019-03-04$36.61/sh+9,280→ 9,280 total
Award
ENANTA PHARMACEUTICALS INC$ENTA
Stock Option (right to buy)
2019-02-28+5,000→ 5,000 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Stock Option (Right to Buy)
2019-02-12−7,500→ 0 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2019-02-12$25.58/sh+3,728→ 3,728 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2019-02-12$90.07/sh−11,228→ 0 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Stock Option (Right to Buy)
2019-02-12−3,728→ 0 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2019-02-12$29.02/sh+7,500→ 11,228 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Stock Option (Right to Buy)
2019-02-11−2,272→ 3,728 total
Exercise/Conversion
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2019-02-11$25.58/sh+2,272→ 2,272 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2019-02-11$90.03/sh−2,272→ 0 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2019-01-22+20,000→ 20,000 total
Award
ENANTA PHARMACEUTICALS INC$ENTA
Stock Option (right to buy)
2018-02-28+7,500→ 7,500 total

Companies

Recent Filings

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465

View on SEC.gov